Cadila falls on earnings, broker downgrades
MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.
Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.
Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.
(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday. Full Article
Top rice exporter India importing over 100,000 T on temporary supply squeeze. Full Article